Legal & General Group
SLRN

Legal & General Group’s ACELYRIN SLRN Stock Holding History

Legal & General Group’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,625
Closed -$16.3K – 3527
2025
Q1 		$16.3K Hold
6,625
– – ﹤0.01% 3020
2024
Q4 		$20.8K Hold
6,625
– – ﹤0.01% 3006
2024
Q3 		$32.7K Buy
6,625
+672
+11% +$3.47K ﹤0.01% 2871
2024
Q2 		$26.2K Sell
5,953
-708
-11% -$3.32K ﹤0.01% 2918
2024
Q1 		$44.9K Sell
6,661
-23,985
-78% -$182K ﹤0.01% 2790
2023
Q4 		$229K Hold
30,646
– – ﹤0.01% 2679
2023
Q3 		$312K Buy
+30,646
New +$651K ﹤0.01% 2618

Other funds holding SLRN

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Legal & General Group's SLRN Position: Q2 2025 in Review

Legal & General Group sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 6,625 shares — an estimated $16.3K sold.

Legal & General Group first reported a position in SLRN in Q3 2023 and held it in 7 quarters. The position peaked at $312K in Q3 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Legal & General Group reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 6,625 ACELYRIN shares in Q2 2025, an estimated $16.3K.
  • Legal & General Group first reported a position in ACELYRIN in Q3 2023 and held it in 7 quarters.
  • Legal & General Group's ACELYRIN position peaked at $312K in Q3 2023.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.